(Q35917130)

11 August 2017

1 reference

title

Antibiotic resistance in Staphylococcus aureus: concerns, causes and cures (English)

1 reference

11 August 2017

main subject

antibiotic resistance

1 reference

based on heuristic

inferred from title

Staphylococcus aureus

object named as

Staphylococcus aureus

1 reference

1

Ian Chopra

1 reference

11 August 2017

publication date

1 June 2003

1 reference

Expert Review of Anti-infective Therapy

11 August 2017

published in

1 reference

11 August 2017

volume

1

1 reference

11 August 2017

issue

1

1 reference

11 August 2017

page(s)

45-55

1 reference

Changing patterns of infectious disease

11 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14787210.1.1.45

The future challenges facing the development of new antimicrobial drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.1.1.45

Preliminary analysis of the genetic basis for vancomycin resistance in Staphylococcus aureus strain Mu50.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.1.1.45

VanA-mediated high level glycopeptide resistance in MRSA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.1.1.45

Linezolid resistance in a clinical isolate of Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.1.1.45

Novel anti-staphylococcal targets and compounds.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.1.1.45

Novel agents for the treatment of resistant Gram-positive infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.1.1.45

The crisis in antibiotic resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.1.1.45

An elevated mutation frequency favors development of vancomycin resistance in Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.1.1.45

Response of Escherichia coli hypermutators to selection pressure with antimicrobial agents from different classes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.1.1.45

Antimicrobials: new solutions badly needed

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.1.1.45

Linezolid resistance in Staphylococcus aureus: characterization and stability of resistant phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.1.1.45

Tetracycline antibiotics: mode of action, applications, molecular biology, and epidemiology of bacterial resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.1.1.45

Clofazimine: a review of its medical uses and mechanisms of action

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.1.1.45

The riminophenazines, clofazimine and B669, inhibit potassium transport in gram-positive bacteria by a lysophospholipid-dependent mechanism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.1.1.45

Antibacterial spectra of drugs used for chemotherapy of mycobacterial infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.1.1.45

Inhibition of potassium transport and growth of mycobacteria exposed to clofazimine and B669 is associated with a calcium-independent increase in microbial phospholipase A2 activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.1.1.45

Research and development of antibacterial agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.1.1.45

N-alkyl urea hydroxamic acids as a new class of peptide deformylase inhibitors with antibacterial activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.1.1.45

21 January 2018

Identifiers

DOI

10.1586/14787210.1.1.45

1 reference

11 August 2017

1 reference